Study to Evaluate TNX-601 ER Monotherapy Versus Placebo in Patients With Major Depressive Disorder (MDD)
Public ClinicalTrials.gov record NCT05686408. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy, Safety, and Tolerability of TNX-601 ER Monotherapy Versus Placebo in Patients With Major Depressive Disorder (MDD)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a Phase 2, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy, safety, and tolerability of TNX-601 ER monotherapy versus placebo in patients with Major Depressive Disorder (MDD).
Study identification
- NCT ID
- NCT05686408
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 132 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 2, 2023 (Actual)
- Primary completion
- Sep 29, 2023 (Actual)
- Completion
- Sep 29, 2023 (Actual)
- Last update posted
- Feb 17, 2025
2023
United States locations
- U.S. sites
- 27
- U.S. states
- 13
- U.S. cities
- 27
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Preferred Research Partners | Little Rock | Arkansas | 72211 | — |
| Cenexel CIT - Bellflower | Bellflower | California | 90706 | — |
| Behavioral Research Specialists | Glendale | California | 91206 | — |
| Synergy Research | Lemon Grove | California | 91945 | — |
| Excell Research | Oceanside | California | 92056 | — |
| NCR Research Institute | Orange | California | 92868 | — |
| Cenexel CIT - Riverside | Riverside | California | 92506 | — |
| Artemis Institute for Clinical Research | San Diego | California | 92103 | — |
| Cenexel CNR - Sherman Oaks | Sherman Oaks | California | 91403 | — |
| Viking Clinical Research | Temecula | California | 92951 | — |
| Mountain View Clinical Research | Denver | Colorado | 80209 | — |
| CT Clinical Research Associates | Cromwell | Connecticut | 06416 | — |
| Gulfcoast Clinical Research Center | Fort Myers | Florida | 33912 | — |
| Clinical Neuroscience Solutions - Jacksonville | Jacksonville | Florida | 32256 | — |
| West Broward Outpatient Clinic | Lauderhill | Florida | 33319 | — |
| Segal Trials - North Miami | Miami Lakes | Florida | 33016 | — |
| Clinical Neuroscience Solutions - Orlando | Orlando | Florida | 32801 | — |
| Cenexel ACMR - Atlanta | Atlanta | Georgia | 30331 | — |
| Cenexel Research - Decatur | Decatur | Georgia | 30030 | — |
| Northwest Clinical Trials | Boise | Idaho | 83704 | — |
| Chicago Research Center | Chicago | Illinois | 60634 | — |
| Cenexel HRI - Berlin | Berlin | New Jersey | 08009 | — |
| Summit Research Network | Portland | Oregon | 97210 | — |
| Clinical Neuroscience Solutions - Memphis | Memphis | Tennessee | 38119 | — |
| Donald J. Garcia, Jr. | Austin | Texas | 78737 | — |
| Futuresearch Trials of Dallas | Dallas | Texas | 75231 | — |
| Core Clinical Research | Everett | Washington | 98201 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05686408, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 17, 2025 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05686408 live on ClinicalTrials.gov.